Clinical Trial: A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants
Study Status: Completed
Recruit Status: Completed
Condition: Healthy
Study Type: Interventional
Official Title: An Open-Label, Fixed-Sequence Study to Evaluate the Effect of Multiple Doses of LOXO-292 on the Single Dose Pharmacokinetics of Repaglinide in Healthy Adult Subjects
Brief Summary:
The main purpose of this study is to assess the effect of selpercatinib on how fast repaglinide gets into the blood stream and how long it takes the body to remove it when administered in healthy participants. Information about safety and tolerability will be collected. The study will last up to 12 days.
Read more